These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 36400568)

  • 1. Apolipoprotein L1 Genotypes and the Association of Urinary Potassium Excretion with CKD Progression.
    Ilori TO; Liu J; Rodan AR; Verma A; Mills KT; He J; Winkler CA; Dupuis J; Anderson CAM; Waikar SS
    Clin J Am Soc Nephrol; 2022 Oct; 17(10):1477-1486. PubMed ID: 36400568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Examination of Potential Modifiers of the Association of APOL1 Alleles with CKD Progression.
    Chen TK; Choi MJ; Kao WH; Astor BC; Scialla JJ; Appel LJ; Li L; Lipkowitz MS; Wolf M; Parekh RS; Winkler CA; Estrella MM; Crews DC
    Clin J Am Soc Nephrol; 2015 Dec; 10(12):2128-35. PubMed ID: 26430087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of Kidney Function Decline Associated with APOL1 Genotypes: Results from AASK.
    Tin A; Grams ME; Estrella M; Lipkowitz M; Greene TH; Kao WHL; Li L; Appel LJ
    Clin J Am Soc Nephrol; 2016 Aug; 11(8):1353-1359. PubMed ID: 27230965
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Chen TK; Tin A; Peralta CA; Appel LJ; Choi MJ; Lipkowitz MS; Winkler CA; Estrella MM
    Clin J Am Soc Nephrol; 2017 Nov; 12(11):1771-1777. PubMed ID: 29051146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and Genetic Characteristics of CKD Patients with High-Risk APOL1 Genotypes.
    Elliott MD; Marasa M; Cocchi E; Vena N; Zhang JY; Khan A; Krishna Murthy S; Bheda S; Milo Rasouly H; Povysil G; Kiryluk K; Gharavi AG
    J Am Soc Nephrol; 2023 May; 34(5):909-919. PubMed ID: 36758113
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Chaudhary NS; Moore JX; Zakai NA; Judd SE; Naik RP; Limou S; Cushman M; Lange LA; Wang HE; Winkler CA; Irvin MR; Kopp JB; Gutiérrez OM
    Clin J Am Soc Nephrol; 2019 Dec; 14(12):1733-1740. PubMed ID: 31704668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dietary Patterns, Apolipoprotein L1 Risk Genotypes, and CKD Outcomes Among Black Adults in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Cohort Study.
    Ilori TO; Brooks MS; Desai PN; Cheung KL; Judd SE; Crews DC; Cushman M; Winkler CA; Shlipak MG; Kopp JB; Naik RP; Estrella MM; Gutiérrez OM; Kramer H
    Kidney Med; 2023 May; 5(5):100621. PubMed ID: 37229446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. APOL1 Nephropathy Risk Alleles and Mortality in African American Adults: A Cohort Study.
    Gutiérrez OM; Irvin MR; Zakai NA; Naik RP; Chaudhary NS; Estrella MM; Limou S; Judd SE; Cushman M; Kopp JB; Winkler CA
    Am J Kidney Dis; 2020 Jan; 75(1):54-60. PubMed ID: 31563468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined Effects of GSTM1 Null Allele and APOL1 Renal Risk Alleles in CKD Progression in the African American Study of Kidney Disease and Hypertension Trial.
    Bodonyi-Kovacs G; Ma JZ; Chang J; Lipkowitz MS; Kopp JB; Winkler CA; Le TH
    J Am Soc Nephrol; 2016 Oct; 27(10):3140-3152. PubMed ID: 26940095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary Potassium Excretion and Progression of CKD.
    Kim HW; Park JT; Yoo TH; Lee J; Chung W; Lee KB; Chae DW; Ahn C; Kang SW; Choi KH; Han SH;
    Clin J Am Soc Nephrol; 2019 Mar; 14(3):330-340. PubMed ID: 30765533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strict blood pressure control associates with decreased mortality risk by APOL1 genotype.
    Ku E; Lipkowitz MS; Appel LJ; Parsa A; Gassman J; Glidden DV; Smogorzewski M; Hsu CY
    Kidney Int; 2017 Feb; 91(2):443-450. PubMed ID: 27927600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Race, APOL1 Risk Variants, and Clinical Outcomes among Older Adults: The ARIC Study.
    Chen TK; Coresh J; Daya N; Ballew SH; Tin A; Crews DC; Grams ME
    J Am Geriatr Soc; 2021 Jan; 69(1):155-163. PubMed ID: 32894582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary Sodium and Potassium Excretion and CKD Progression.
    He J; Mills KT; Appel LJ; Yang W; Chen J; Lee BT; Rosas SE; Porter A; Makos G; Weir MR; Hamm LL; Kusek JW;
    J Am Soc Nephrol; 2016 Apr; 27(4):1202-12. PubMed ID: 26382905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic Inhibition of APOL1 Pore-Forming Function Prevents APOL1-Mediated Kidney Disease.
    Hung AM; Assimon VA; Chen HC; Yu Z; Vlasschaert C; Triozzi JL; Chan H; Wheless L; Wilson O; Shah SC; Mack T; Thompson T; Matheny ME; Chandrasekar S; Mozaffari SV; Chung CP; Tsao P; Susztak K; Siew ED; Estrada K; Gaziano JM; Graham RR; Tao R; Hoek M; Robinson-Cohen C; Green EM; Bick AG;
    J Am Soc Nephrol; 2023 Nov; 34(11):1889-1899. PubMed ID: 37798822
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Gutiérrez OM; Irvin MR; Chaudhary NS; Cushman M; Zakai NA; David VA; Limou S; Pamir N; Reiner AP; Naik RP; Sale MM; Safford MM; Hyacinth HI; Judd SE; Kopp JB; Winkler CA
    Circ Genom Precis Med; 2018 Jun; 11(6):e002098. PubMed ID: 29899045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kidney Disease Progression in Membranous Nephropathy among Black Participants with High-Risk APOL1 Genotype.
    Chen DP; Henderson CD; Anguiano J; Aiello CP; Collie MM; Moreno V; Hu Y; Hogan SL; Falk RJ;
    Clin J Am Soc Nephrol; 2023 Mar; 18(3):337-343. PubMed ID: 36763808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein L1 High-Risk Genotypes and Albuminuria in Sub-Saharan African Populations.
    Brandenburg JT; Govender MA; Winkler CA; Boua PR; Agongo G; Fabian J; Ramsay M
    Clin J Am Soc Nephrol; 2022 Jun; 17(6):798-808. PubMed ID: 35577564
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Doshi MD; Ortigosa-Goggins M; Garg AX; Li L; Poggio ED; Winkler CA; Kopp JB
    J Am Soc Nephrol; 2018 Apr; 29(4):1309-1316. PubMed ID: 29339549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum 6-Bromotryptophan Levels Identified as a Risk Factor for CKD Progression.
    Tin A; Nadkarni G; Evans AM; Winkler CA; Bottinger E; Rebholz CM; Sarnak MJ; Inker LA; Levey AS; Lipkowitz MS; Appel LJ; Arking DE; Coresh J; Grams ME
    J Am Soc Nephrol; 2018 Jul; 29(7):1939-1947. PubMed ID: 29777021
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasma apolipoprotein L1 levels do not correlate with CKD.
    Bruggeman LA; O'Toole JF; Ross MD; Madhavan SM; Smurzynski M; Wu K; Bosch RJ; Gupta S; Pollak MR; Sedor JR; Kalayjian RC
    J Am Soc Nephrol; 2014 Mar; 25(3):634-44. PubMed ID: 24231663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.